Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia.

TNF has a critical mediator role in inflammation and is an important therapeutic target. We recently discovered that TNF production is regulated by neural signals through the vagus nerve. Activation of this "cholinergic antiinflammatory pathway" inhibits the production of TNF and other cytokines and protects animals from the inflammatory damage caused by endotoxemia and severe sepsis. Here, we describe a role for central muscarinic acetylcholine receptors in the activation of the cholinergic antiinflammatory pathway. Central muscarinic cholinergic activation by muscarine, the M1 receptor agonist McN-A-343, and the M2 receptor antagonist methoctramine inhibited serum TNF levels significantly during endotoxemia. Centrally administered methoctramine stimulated vagus-nerve activity measured by changes in instantaneous heart-rate variability. Blockade of peripheral muscarinic receptors did not abolish antiinflammatory signaling through the vagus nerve, indicating that peripheral muscarinic receptors on immune cells are not required for the cytokine-regulating activities of the cholinergic antiinflammatory pathway. The role of central muscarinic receptors in activating the cholinergic antiinflammatory pathway is of interest for the use of centrally acting muscarinic cholinergic enhancers as antiinflammatory agents.

[1]  K. Tracey.  Fatal Sequence: The Killer Within , 2005 .

[2]  T. Gotoh,et al.  Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice , 2005, Breast Cancer Research.

[3]  V. Pavlov,et al.  Neural regulators of innate immune responses and inflammation , 2004, Cellular and Molecular Life Sciences CMLS.

[4]  R. Langley,et al.  Central but not the peripheral action of cholinergic compounds suppresses the immune system , 2004, Journal of Neuroimmunology.

[5]  C. Owyang,et al.  Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat , 2003 .

[6]  K. Jacobson,et al.  Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats , 2003, Autonomic Neuroscience.

[7]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.

[8]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[9]  S. Tayebati,et al.  Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes , 2002, Journal of Neuroimmunology.

[10]  K. Tracey,et al.  Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway , 2002, The Journal of experimental medicine.

[11]  J. Wess,et al.  Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice , 2002, The Journal of Neuroscience.

[12]  C. Strader,et al.  Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. , 2001, Life sciences.

[13]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[14]  P. Luiten,et al.  Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory , 1999, Progress in Neurobiology.

[15]  R. Quirion,et al.  Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus. , 1999, Brain research. Molecular brain research.

[16]  Eszter Farkas,et al.  Periaqueductal gray matter projection to vagal preganglionic neurons and the nucleus tractus solitarius , 1997, Brain Research.

[17]  B. Shukitt-Hale,et al.  Effects of M2 antagonists on in vivo hippocampal acetylcholine levels , 1996, Brain Research Bulletin.

[18]  K. Dobashi,et al.  Induction of muscarinic receptor subtypes in monocytic/macrophagic cells differentiated from EoL-1 cells. , 1996, European journal of pharmacology.

[19]  R. Mcquade,et al.  Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data. , 1995, The Journal of pharmacology and experimental therapeutics.

[20]  A. Parent,et al.  Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  B. Shukitt-Hale,et al.  Elevation of hippocampal extracellular acetylcholine levels by methoctramine , 1993, Brain Research Bulletin.

[22]  D. Remick,et al.  In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. , 1991, The American journal of pathology.

[23]  J. C. Hancock,et al.  Effect of vagotomy on cholinergic parameters in nuclei of rat medulla oblongata , 1985, Brain Research Bulletin.

[24]  E. Masini,et al.  Muscarinic cholinergic receptor binding in rat mast cells , 1983, Agents and Actions.

[25]  T. Shimazu,et al.  Chemical coding of the hypothalamic neurones in metabolic control. I. Acetylcholine-sensitive neurones and glycogen synthesis in liver , 1979, Brain Research.

[26]  T. Shimazu,et al.  Cholinergic stimulation of the rat hypothalamus: effects of liver glycogen synthesis. , 1976, Science.

[27]  B. Ryffel,et al.  Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.

[28]  J. Wess.  Molecular biology of muscarinic acetylcholine receptors. , 1996, Critical reviews in neurobiology.

[29]  A. Loewy.  Chapter 12 Forebrain nuclei involved in autonomic control , 1991 .

[30]  K. M. Spyer,et al.  Central regulation of autonomic functions , 1990 .

[31]  L W Swanson,et al.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. , 1983, Annual review of neuroscience.